EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and delivering innovative…
Arboretum_JDMarch 23, 2022
EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and delivering…
Casey FrushourJanuary 10, 2022
CM Life Sciences III (Nasdaq: CMLT, CMLTW, CMLTU), a life science-focused special purpose acquisition company,…
Arboretum_JDDecember 17, 2021
EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines…
Arboretum_JDDecember 2, 2021
EQRx Announces Partnership Agreement with Abdul Latif Jameel Health to Commercialize Lead Oncology Programs in…
Arboretum_JDNovember 22, 2021
EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines…
Arboretum_JDOctober 20, 2021
Turning Point Therapeutics and EQRx Announce Clinical Collaboration to Evaluate Elzovantinib in Combination with Aumolertinib…
Arboretum_JDOctober 14, 2021
EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines…
Arboretum_JDOctober 7, 2021
EQRx, Inc., a new type of pharmaceutical company committed to developing and delivering important new…
Arboretum_JDAugust 6, 2021
